JPRN-UMIN000011071招募中4 期
Clinical efficacy of anagliptin administration in type 2 diabetic patients - Clinical efficacy of anagliptin administration in type 2 diabetic patients
Kuwana East Medical Center Cardiology0 个研究点目标入组 40 人开始时间: 2013年6月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Out of above criteria
研究者
相似试验
已完成
不适用
Evaluation of the clinical efficacy of anagliptin in type 2 diabetic patients with diabetic nephropathy.JPRN-UMIN000012802Kanazawa Medical University Diabetology and Endocrinology50
已完成
不适用
Study of the effect of Anagliptin administration on the activity of glucagon after test meal loadingPatients with type II diabetes mellitusJPRN-UMIN000021102Arc Cardiovascular Clinic20
已完成
不适用
ong-term efficacy of anagliptin in patients with type 2 diabetes mellitusType 2 Diabetes MellitusJPRN-UMIN000048203aka Kinen Clinic299
已完成
不适用
The efficacy of anagliptin in patients with type 2 diabetes mellitusJPRN-UMIN000027103Juntendo University Urayasu Hospital30
已完成
不适用
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney diseaseType 2 Diabetic Patients with chronic kidney DiseaseJPRN-UMIN000008133Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine50